Type 2 Diabetes: Clinical Diagnosis, HbA1c Cutoffs, Pharmacotherapy, and Remission Protocols
Type 2 Diabetes is a progressive metabolic disease that causes insulin resistance in peripheral tissues and progressive dysfunction of pancreatic β cells. This article will discuss the current diagnostic criteria set forth by the American Diabetes Association (ADA), modern cardioprotective therapies such as GLP-1 RA and SGLT2 inhibitors, as well as Continuous Glucose Monitoring (CGM) and diabetes remission therapies.